Aegerion Pharmaceuticals Cash from Operations Quarterly
Aegerion Pharmaceuticals Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -12.71M |
| Sept. 30, 2012 | -10.84M |
| June 30, 2012 | -10.22M |
| March 31, 2012 | -8.794M |
| Dec. 31, 2011 | -9.082M |
| Sept. 30, 2011 | -7.479M |
| June 30, 2011 | -6.938M |
| March 31, 2011 | -7.010M |
| Dec. 31, 2010 | -3.980M |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
AEGR Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Isis Pharmaceuticals | -10.58M |
| Sanofi | |
| Keryx Biopharmaceuticals | -5.566M |
AEGR Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -12.71M | Dec 2012 |
| Maximum | -0.0354M | Mar 2010 |
| Average | -6.882M |
